Patients harboring BRAF mutations were younger (median age 51 years), predominantly male, and most frequently were diagnosed with nodular melanoma subtype—a pattern that aligns with previous cohorts where nodular melanoma is commonly associated with BRAF mutations (68, 71). The gene discussed is BRAF; the disease is nodular malignant melanoma.